Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 17, 2017
Guardant Health has added Bristol-Myers Squibb to the group of pharmaceutical companies it is working with to develop the GuardantOMNI assay.
read more
GT Biopharma and CDMO Cytovance have reached an agreement for license rights to use certain bacterial and mammalian cell lines and for GMP manufacturing services performed to date regarding the Company's TriKE™ product candidates.
read more
Wednesday, February 24, 2021
GT Biopharma has signed an expanded GMP manufacturing agreement with Cytovance Biologics for the manufacture of all TriKEs™.
read more
Thursday, August 13, 2015
The medications produced at a GlaxoSmithKline pharmaceutical plant are safe despite the decision to close the factory after the discovery of the bacteria that causes potentially fatal Legionnaires' disease, the company said Wednesday.
read more
Specialist in early genotoxicity screening and mechanistic follow-up, Gentronix, is pleased to announce the findings of new research published by GlaxoSmithKline (GSK) on the miniaturisation and automation of BlueScreen™ HC; a proprietary assay ...
read more
GSK has announced $100 million of new investment in its manufacturing site in Montana to expand production capacity of key components of the adjuvant system used in several of GSK's vaccines.
read more
Wednesday, March 17, 2021
CGT Catapult announced GSK will leverage the CGT Catapult Stevenage facility to perform GMP cell processing to accelerate its cell and gene therapy pipeline for clinical trials.
read more
Monday, December 28, 2015
GlaxoSmithKline has announced the completion of its transaction to divest its rights to ofatumumab for auto-immune indications to Novartis Pharma AG, a subsidiary of Novartis AG, following regulatory approval.
read more
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more
Guadalupe, Nuevo León, Grupo Yacana México S.A.S de C.V. is voluntarily recalling All Lots of Yacana Hand Sanitizer, 70% Alcohol, 250 ml to the consumer level.
read more
Monday, December 12, 2016
Grünenthal Group has entered into a definitive agreement with Astellas Pharma Europe Ltd., the European subsidiary of Tokyo-based Astellas Pharma Inc., for the exclusive rights to the dermal patch Qutenza® (capsaicin 8%) in Europe, Middle East and ...
read more
Wednesday, February 25, 2015
The lack of biosimilars in the growth hormone deficiency (GHD) treatment pipeline does not signify a missed opportunity, because superior products exist in the form of next-generation biologics known as biobetters, says an analyst with research and ...
read more
Groupe PARIMA, a Quebec-based CDMO specializing in non-sterile liquid, suspension, semi-solid and spray drug products, has joined the Pharma & Biopharma Outsourcing Association (PBOA), the trade association for CMOs and CDMOs, as a General Member.
read more
Wednesday, January 20, 2021
Gritstone has obtained a nonexclusive license to Genevant’s LNP technology to develop and commercialize SAM vaccines against SARS-CoV-2.
read more
Grifols announced that it has restated its 2005 agreement with OraSure Technologies. Additionally, Grifols is building a biological manufacturing facility in the San Francisco Bay Area.
read more